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ABSTRACT 
 
The aim of this thesis was to investigate the association between drinking water fluoride 
exposure and risk of hip fracture, myocardial infarction, and osteosarcoma. Swedish nation-
wide population-based registers have been used throughout the thesis. 
The risk of hip fracture was addressed in a population-based cohort of 452,824 eligible 
individuals with an estimated exposure to the same drinking water source from birth upon 
start of follow-up, (i.e. living in their municipality of birth). Information on residence from 
parish records was used to address a community water supplier for each individual in the 
cohort. The drinking water fluoride levels in our cohort ranged between <0.1 and 2.7 mg/L. 
We linked the Total Population Register, the National Patient Register, and the Swedish 
Death Register. We studied the association between drinking water fluoride level and risk of 
hip fracture. We found no association between fluoride exposure level and risk of hip fracture 
(compared to the very low exposure group, adjusted Hazard Ratio (aHR) for the low 
exposure group was 0.97; 95% CI = 0.94-0.99, aHR for the medium exposure group was 
0.97; 95% CI = 0.94-1.00, and aHR for the highest exposure group was 0.98; 95% CI 0.93-
1.04). Nor did we find an association between fluoride level and the risk of osteoporotic (low-
trauma) hip fracture. Stratified analyses suggested that fluoride exposure in individuals 
younger than 80 years of age was associated with a decreased risk for hip fracture. However, 
no clear exposure-response effect was observed. We cannot rule out that unmeasured 
confounding may have influenced the observed results. 
The risk of myocardial infarction was addressed in a population-based cohort of 455,619 
eligible individuals with an estimated exposure to the same drinking water source from birth 
upon start of follow-up, (i.e. living in their municipality of birth). The fluoride exposure 
assessments and the retrieval of register data were performed in a similar manner as in study I 
(described above). The drinking water fluoride levels in our cohort ranged between <0.1 and 
2.7 mg/L. We studied the association between drinking water fluoride level and risk of 
myocardial infarction. We found no association between fluoride exposure level and risk of 
myocardial infarction (compared to the very low exposure group, aHR for the low exposure 
group was 1.00; 95% CI 0.99-1.02, aHR for the medium exposure group was 1.02; 95% CI 
0.99-1.04, and aHR for the highest exposure group was 1.01; 95% CI 0.98-1.04). Additional 
analyses was performed, looking at fatal and non-fatal myocardial infarction. No association 
was found. We found some evidence of a positive association between fluoride exposure 
level and risk of myocardial infarction in the northern part of Sweden (compared to the very 
low exposure group, aHR for the low exposure group was 1.04; 95% CI 1.00-1.07, aHR for 
the medium exposure group was 1.12; 95% CI 1.07-1.16, and aHR for the highest exposure 
group was 1.09; 95% CI 1.02-1.17). This association may in part be explained by unmeasured 
confounding. Moreover, only a small effect size is detected, and in combination with the 
large sample size and total number of events, we consider that this finding is unlikely to be of 
significance. 
The risk of osteosarcoma was addressed in a population-based case-control study consisting 
of 363 eligible osteosarcoma cases identified in the Swedish Cancer Register, and 1,815 
control subjects randomly selected from the Total Population Register, and matched to cases 
(5:1) on birth year and sex. A control had to be alive and without an osteosarcoma diagnosis 
at the time of selection. All domestic movements and migrations (dates and locations) were 
collected for all cases and controls, from birth upon index date (date for cancer diagnosis). 
Information on residence was used to address a community water supplier for each individual 
in the cohort. The drinking water fluoride levels in our cohort ranged between 0.03 and 2.75 
mg/L (ppm). We linked the Swedish Cancer Register, the National Patient Register, the Total 
Population Register, and The Register of Population and Population Changes. We studied the 
association between accumulated drinking water fluoride exposure and risk of osteosarcoma. 
Different exposure-times before osteosarcoma diagnosis were studied, as well as different 
exposure-ages, to evaluated potential important time-windows for exposure. We found no 
association between drinking water fluoride exposure and risk of osteosarcoma (aOR 0.99; 
95% CI 0.67-1.16). However, this study has a few important limitations. We lack information 
on potential confounders such as additional socioeconomic variables and height at diagnosis. 
Moreover, misclassification of exposure when we only assess fluoride exposure from 
drinking water, other dietary source for fluoride (food, beverages, and dental hygiene 
products) might account for an important part of the total fluoride load. And additionally, 
non-differential misclassification of exposure (i.e. individuals categorized as exposed could in 
fact be unexposed and vice versa). We cannot rule out that the above mentioned 
methodological limitations may have influenced the results. 
In conclusion, fluoride exposure from municipal drinking water does not appear to be 
associated with increased risk for hip fracture, myocardial infarction, or osteosarcoma in 
Sweden. This is in agreement with most findings from previous studies assessing similar 
drinking water fluoride exposure levels. The results of this thesis add to the body of evidence 
that ingestion of lower fluoride concentrations (<4 mg/L) is not associated with increased risk 
of adverse health effects.  
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1 INTRODUCTION 
 
The use of fluoride in caries prevention is regarded as one of the greatest interventions in 
medicine1, but its appropriateness has been intensely debated throughout the world. 
Opponents have raised doubts about safety, ethics, adverse health effects, and effectiveness of 
fluoride on oral health.2 
The presence of fluoride in the caries prevention regime is a necessity, and large populations 
are exposed daily via drinking water, food (such as table salt and milk), or dental hygiene 
products. The benefits of topical fluorides (presented in the oral cavity), and low intake of 
fluoride (via drinking water for example) for dental caries prevention are firmly established; 
however, during childhood years slightly higher levels can lead to dental fluorosis, a 
mineralization disorder of the dental enamel.2-4 Prolonged fluoride intake, at any age, may 
result in skeletal fluorosis, a condition with increased bone density and brittleness, with a 
potential increase in fracture risk.2,3,5 In severe cases, where the ingested fluoride dose is very 
high, calcifications of ligaments and bone deformations may develop and cripple the 
individual.5 Other adverse health effects such as cancer (osteosarcoma in particular), effects 
on the thyroid, and effects on the developing brain have been reported to be associated with 
ingested fluoride. However, despite the extensive research conducted over the last 50 years, 
the quality of the evidence of both the beneficial and harmful effects of fluoride is 
surprisingly poor. Studies often lack the appropriate study design and statistical methodology.  
In this thesis we have used register data from national health and census registries, and 
historical drinking water data, to investigate the association between drinking water fluoride 
and the risk for hip fracture, myocardial infarction, and osteosarcoma. In the study design 
chosen and in the applied statistical analyses, we tried to avoid some of the shortcomings of 
the previous studies.
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2 BACKGROUND 
 
Fluoride is a halogen and the 13th most common element in the earth’s crust, and thereby 
found in literally all living and non-living things in a broad range of concentrations.6 The 
concentration of fluoride in water and food is dependent on geological conditions (such as 
soil and rainfall), and large geographical variations are seen.  
Today over 377 million people in 28 countries live in areas with artificially fluoridated 
drinking water (for caries prevention), and a further 257 million people live in areas with 
naturally occurring fluoride levels.7,8 
 
2.1 HISTORY OF FLUORIDE IN DENTISTRY 
 
The link between oral health and fluoride dates back to the 1930s. In the late 1930s and 1940s 
both experimental and epidemiological studies identified the anti-cariogenic effect of 
fluoride.9-13 Though, the discovery of fluorides anti-cariogenic effect was derived from 
observations in the early 20th century of mottled enamel (brown stains) in residents from 
Colorado Springs (USA).14 Natural occurring fluoride in the drinking water was found to be 
the responsible cause for the enamel disturbance and discoloration, and subsequent named 
enamel fluorosis.15-18 Studies on the prevalence of enamel fluorosis was investigated and 
when compared to the prevalence of dental caries an inverse relation was found.9,11 
Moreover, a dose-response pattern was observed between ingested fluoride from drinking 
water and dental fluorosis, water containing 1.0 mg/L of fluoride had a caries-protective 
effect with only very mild or mild forms of dental fluorosis.10,12 
This discovery was followed by the hypothesis that adjustments of the drinking water 
fluoride levels to 1.0 to 1.2 mg/L could prevent dental caries. The hypothesis was tested in 
four pairs of cities in the USA and Canada, and resulted in a 50 to 70% caries incidence 
reduction in children, over a time period of 13-15 years.19 After additional epidemiological 
studies on drinking water consumption in different geographical regions and climates the 
recommended level of fluoride in drinking water was lowered and set to 0.7 to 1.2 mg/L 
depending on climate (i.e. warmer climate equals to higher water consumption).20 Water 
fluoridation was subsequently adapted in many countries where the fluoride level was 
considered deficient. 
WHOs recommendations today are that artificially fluoridated drinking water should not 
exceed 1.0 mg/L, and that naturally occurring drinking water fluoride should not exceed 1.5 
mg/L.7 Recently, the US Department of Health and Human Services set the recommended 
level to 0.7 mg/L “the concentration that provides the best balance of protecting from dental 
caries while limiting the risk of dental fluorosis”.21  
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In addition to adding fluoride to drinking water, other fluoride containing products 
(toothpaste, gels, tablets, mouth rinses, and food such as table salt and milk) were rapidly 
developed for dental caries prevention purpose. Initially it was believed that the systemic 
effect from fluoride on the developing enamel (preeruptively) prevented the development of 
dental caries. In the 1970s it was shown that the main effect from fluoride was due to its 
presence in the oral cavity.22-24 Today, all caries preventive, and treatment methods using 
fluoride aim to supply fluoride to the oral environment (via drinking water, oral hygiene 
products, or food stuff), where it can pursue its effect on caries control.22 
 
2.2 SOURCE OF FLUORIDE EXPOSURE 
 
Human exposure to fluoride is mainly attributed to the diet (fluoride containing drinking 
water, other non-diary beverages, and food), and fluoride-containing oral hygiene products.25 
Though, fluoride is also found in air (dust, smoke) and chemicals (pesticides), but exposure 
from inhalation or dermal exposure are judged to be limited in industrialized countries, 
except for individuals having occupational exposure (industries).2,26 
 
Drinking water 
Drinking water is the most significant source of fluoride exposure, both historically and in 
modern times, according to large reports from Europe and the US.2,27 Ground water has 
usually higher fluoride content than surface water (usually < 0.5 mg/L) and sea water (usually 
1.2 to 1.5 mg/L).6 The maximum concentrations of fluoride found in water are reaching 30 to 
50 mg/L.28 The natural fluoride concentrations found in European countries is generally 
believed to be low, but the geographical differences are large. According to EFSA there are 
no available systematic register data on drinking water content in European countries, but 
large variations are not only seen between different countries but also within countries.25 
When the Scientific Committee on Health and Environmental Risks conducted a critical 
review on human exposure to fluoride, they estimated that the mean value of the lowest 
fluoride concentration in European drinking water was 0.1 mg/L and the highest 3.0 mg/L.27 
In countries and geographical areas were the tap water is fluoridated (for cariostatic purposes) 
the concentration is around 1.0 mg/L. The tap water in Sweden is not artificially fluoridated, 
the fluoride found in drinking water is all naturally present. In some parts of Sweden the 
fluoride concentration is above the recommended limit for fluoride (above 1.5 mg/L), in 
particular private wells may have elevated fluoride concentrations.29 
The level of exposure is not only dependent on the fluoride concentration in the drinking 
water, both the amount ingested and body weight are crucial.30 According to European data 
on adult populations, the consumption pattern shows large differences; from 0.7 L/person/day 
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to 3.8 L/person/day across countries (median consumption 1.3 L/person/day).25 The variance 
was attributed to human physiology and climate conditions. However, the exposure will 
mainly be dependent on the concentration of fluoride in water.25,27 The WHO use 2.0 
L/person/day as a default value for consumption.7 Water and other liquid consumption data in 
children less than 12 years is estimated to under 0.5 L/person/day, and about 0.6 L/person/day 
for children aged 12 to 15 years.25 However, the available data is sparse. The average 
consumption of tap water in Sweden (adult population) is estimated to be 1.8 L/person/day.31 
 
Food 
The second largest source of exposure is food. The fluoride level in fresh food is dependent 
on where it is processed and the water used, but also dependent on the water it is prepared 
in.32 In Europe the fluoride content in food is generally low, between 0.02 to 0.29 mg/kg, but 
food stuff such as fluoridated table salt, fish, tea and bottled natural mineral water may 
contain higher fluoride concentrations.25,33 The consumption of bottled water is limited in 
Sweden (0.06 L/day) compared to other European countries.31 
 
Dental hygiene products 
The concentration of fluoride in dental hygiene products vary depending on brand, and type 
of product. The upper level of fluoride concentration is 1,500 mg/kg (1.5%), higher 
concentrations may be prescribed for patients with high caries risk. In 2008, the mean 
consumption in Europe of fluoride containing toothpaste was 251 ml/year/person.27 The 
ingestion of fluoride from dental hygiene products is depending on the fluoride concentration 
of the product, the amount used and swallowed.27,34 The amount swallowed may account for 
an important part of the total fluoride load. 
The recommended amount of toothpaste applied on the tooth brush for children is a “pea 
size” (about 0.25 g), and in adults the recommendations is the full length of the brush (about 
0.75 g). In adults, about 10% of the amount of the toothpaste used on the brush is swallowed 
due to the spitting reflex, in children, under 8 years of age, the amount swallowed may be 
over 40% due to a less developed spitting reflex.22 Eating/licking toothpaste is associated 
with a higher risk of fluorosis.35 Additionally, the recommended fluoride concentration of the 
toothpaste is lower for children younger than 6 years of age (0.05 to 0.1% compared to 1.5% 
for older children and adults) due to the potential of swallowing.27 The guidelines for children 
is also parental supervision and assistance when brushing to limit the fluoride ingestion. 
Studies have shown that if guidelines are followed (i.e. “pea size” amount, lower 
concentration of the paste, and parental supervision) the risk for dental fluorosis is 
reduced.36,37 
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2.3 THE FATE OF FLUORIDE 
 
Ingested fluoride is rapidly, and nearly completely, absorbed from the gastrointestinal tract 
and distributed throughout the body.32 Fluoride as hydrofluoric acid (HF) passes cell 
membranes, and plasma fluoride levels are detected within minutes after ingestion, with a 
peak level during the first hour.30 The uptake is reduced when ingested with calcium-rich 
liquids or foods.38,39 However, no difference is found between hard and soft drinking water, 
or between natural and artificially fluoridated drinking water, and the bioavailability of 
fluoride.40-42 The fluoride found in feaces is believed to never have been absorbed from the 
gastrointestinal tract.30 
Once fluoride is absorbed, it is cleared from the plasma through the excretion in urine, and to 
some extent in saliva and sweat, and by the uptake in calcified tissues (Figure 1).32,43,44 About 
50% of the absorbed amount is excreted via urine during the following 24 hours, most of the 
remaining amount is incorporated into calcified tissue. Since fluoride is a keen hard tissue 
seeker, about 99% of the body burden of fluoride is found in calcified tissues such as bone 
(where fluoride ions replace hydroxyl ions in hydroxyapatite crystals), and teeth (during 
preeruptive tooth development).32 Besides bone and teeth, fluoride is also found in the pineal 
gland, another calcifying organ.45 
 
 
Figure 1. A humble illustration of the fate of fluoride. 
 
Fluoride is poorly transferred from plasma to breast milk46, but fluoride crosses via the 
placenta to the fetus, as well as over the blood-brain barrier. The fluoride level in plasma of 
the fetus is the same as in the mother, and fluoride concentrations in brain and fatty tissue are 
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thought to be about 20% of plasma concentration or less.32,47 In most soft tissue the 
concentration of fluoride is the same as in plasma, except for the kidney where the 
concentration is high due to renal handling and elimination of fluoride.32 
 
2.4 THE ACTION OF FLUORIDE 
 
The debate on fluoride and its use in dentistry mainly questions the potential adverse health 
effects from ingested fluoride.21 The suggested health effects have been many over the years. 
I will address the following; dental and skeletal fluorosis, bone fractures, cancer, 
cardiovascular disease, and neurological disease. 
 
Dental effects 
The presence of fluoride ions in the oral cavity (i.e. saliva or biofilm fluid) chemically reduce 
the rate of dental hard tissue demineralization during the caries process, enhance the 
remineralization process of the demineralized tissue, and reduce acidic production by the 
bacteria in the plaque.48,49 
If fluoride is present during enamel formation, from the second fetal month to about 7-8 years 
of age50, the fluoride ion is incorporated into the tooth enamel forming fluoroapatite.51 
Creating a less soluble structure of the enamel, but the preeruptive effect from fluoride on 
caries prevention is limited.52 If excessive concentration of fluoride is present during this 
period in life when enamel formation takes place, enamel fluorosis may occur. The enamel 
disturbance can range from mild discolorations of the enamel to severe pitting and staining.53 
The process of mineralizing dental tissue disturbance is not yet fully understood54, and other 
environmental and genetic factors may influence the development of dental fluorosis.55,56 
The prevalence of enamel fluorosis in populations receiving drinking water with a fluoride 
concentration of 1.0 mg/L is about 48%.10,57 The use of fluoride in young children is a risk-
benefit balance, and both caries disease and enamel fluorosis are health concerns. To consider 
all forms of enamel fluorosis as adverse health effect has been the subject of debate. It has 
been judged to be a cosmetic effect, and in severe cases to be aesthetically displeasing.2,26 
This is largely based on that there is no evidence that fluorosis is associated with tooth loss, 
social, or psychological problems.2,21,26,58 
 
Bone effects 
As mentioned before, fluoride accumulates in calcified tissues throughout life. The retention 
during skeletal growth is higher than during adulthood. In infants, about 90% of ingested 
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amount is retained.47,59 Whereas in an adult situation, 50 % is retained and 50 % is excreted, a 
steady state is reached.32,59,60 Besides fluorides ability to incorporate into calcified tissues, it 
has also been shown that fluoride have potent effects on bone cells, in particular stimulation 
of osteoblast proliferation.61,62 Both bone quality and quantity is affected.32 Populations with 
fluoridated water has been shown to have an increase in bone density.63,64 Fluoride has 
therefore been used in prevention regimes for osteoporosis, but the long term effects on bone 
strength and fracture risk is ambiguous.65-67 
A number of epidemiological studies have investigated the association between fluoride 
exposure at <4.0 mg/L and fracture risk. A recent meta-analysis concluded no definitive 
patterns of association between fluoride exposure and fracture of any sites.57 Studies with 
long duration were found to be the only variable associated with fewer fractures (a protective 
effect from fluoride).57 However, the quality of the studies was low to moderate, and 
significant heterogeneity was found (p<0.001) among studies. Moreover, studies on hip 
fracture were evaluated in a meta-analysis, and findings suggests that there is limited 
evidence that chronic fluoride exposure from drinking water is associated with hip fracture 
risk.68 However, caution is needed in the interpretation of the results due to lack of 
homogeneity, unmeasured confounding, and exposure misclassification. Additionally, 
evidence support the conclusion that increase fracture rates are likely in populations exposed 
to lifetime drinking water fluoride levels above 4.0 mg/L, compared to levels around 1.0 
mg/L.2,69 
As with dental tissue, chronic excessive fluoride intake may also cause skeletal fluorosis, 
with increased bone density, calcifications of ligaments and osteosclerosis, with different 
levels of severity and subsequent increased fracture risk.2 There are limited data on skeletal 
fluorosis at drinking water fluoride levels <4.0 mg/L, and the National Research Council 
conclude that skeletal fluorosis is a rare condition at fluoride levels of 4.0 mg/L, but the 
relationship between ingestion, concentrations found in bone, and level of skeletal fluorosis 
needs more clarifications before any conclusions can be drawn.2 
Bone cancer has also been focus of concern due to fluorides accumulation in bone and the 
ability to stimulate osteoblast proliferation.2,32 Animal studies have found increased 
osteosarcoma incidence in male rats exposed to high fluoride dose.70 Two recent systematic 
reviews evaluating human epidemiological studies on the association between fluoride 
exposure and cancer risk, reported no clear association.57,69 Fluoride exposure at specific time 
windows (ages), has recently been suggested by Bassin et al. (2006)71 to be of importance. 
The authors found an increased risk for osteosarcoma in boys exposed to fluoride at 6 to 8 
years of age (with a peak at 7 years of age, aOR 5.46; 95% CI 1.50 – 19.90), but the need for 
caution in the interpretation of the findings was stressed by the authors, due to 
methodological limitations.71,72 In a subsequent study, where the bone fluoride concentration 
was investigated, (instead of fluoride levels in the drinking water), the findings from Bassin et 
al.71 could not be confirmed.73 Despite the general scientific agreement that there is no 
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evidence of any association between ingested fluoride and increased osteosarcoma risk73-83, 
the debate continuous. 
 
Cardiovascular effects 
In the 1960s and -70s, fluoride was suggested to attribute to the decline in cardiovascular 
death rates observed in the USA and other countries.63,84,85 There were laboratory data86-88 
which suggested that fluoride could have an ability to inhibit soft tissue calcification, and 
additional findings of an association was reported from epidemiological data.63,84,89 Recent 
studies in fluoride endemic areas have demonstrated the opposite; that excessive fluoride 
exposure affect the elastic properties of ascending aorta and moreover contribute to cardiac 
dysfunction.90,91 According to the authors, the possible mechanism behind the findings was 
fluorides toxicological ability to induced oxidative stress and inflammation.92,93 But the 
mechanism behind the impaired elastic properties of aorta is not fully understood. Another 
study of excessive fluoride exposure, found significant associations with carotid 
atherosclerosis development. The mechanism was attributed to decreasing levels of 
glutathione peroxidase by excessive fluoride concentrations, causing systemic inflammation 
and endothelial activation.94,95  
Epidemiological data on fluoride exposure levels <2 mg/L have demonstrated that very low 
drinking water fluoride levels were associated with an increased risk of myocardial 
infarction.89,96-98 But the potential protective effect found on myocardial infarction, is 
suggested to attribute fluorides impact on oral health improvement, i.e. via an indirect 
association.98,99 Chronic low-grade bacterial infections, such as periodontitis and dental 
caries, have been linked to atherosclerosis and cardiovascular disease.99-101 
 
Neurobehavioral effects 
There are limited data on neurobehavioral effects of fluoride in humans. Studies on 
developmental effects of fluoride have mostly been conducted in China. A meta-analysis of 
16 Chinese studies were published by Tang et al. (2008)102, evaluating the influence of 
fluoride on children’s IQ. High incidence of fluorosis and high fluoride air levels were 
associated with a higher odds of developing a low IQ, compared to low fluorosis areas. 
However, the analysis does not follow the praxis of a meta-analysis. Additionally, the 
included studies suffered from confounding, and suboptimal control over water quality. A 
previous report by the Scientific Committee on Health and Environmental Risks stated that 
the biological link for an association between fluoride and IQ has not been established.27 
Grandejean and Landrigan (2014)103 published a review article in Lancet Neurology stating 
children exposed to fluoride had a decrement in IQ.103 This statement was based on studies of 
low quality, however the impact in social media was high. A recent study from New Zealand 
could not confirm the findings from China. No association was found between fluoride 
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exposure (from drinking water, food, and dental hygiene products) and difference in IQ.104 
Adjustments were made for potential confounding factors such as age, sex, socioeconomic 
status, breastfeeding, and birth weight. The exposure levels investigated in the study is more 
relevant to exposure levels found in industrialized countries, and the findings are more 
generalizable to other populations. 
 
2.5 HUMAN EXPOSURE 
 
Exposure to fluoride vary substantially between individuals as well as between populations, 
dependent on drinking water source, dietary habits, and dental hygiene regimes. The intense 
debate over fluoride and its use in dentistry has led to several scientific investigations on 
fluoride and its hazard profile.2,25,26,105,106 In 1986 the U.S. Environmental Protection Agency 
(EPA) established exposure standards for contaminants in the public drinking water.² 
Contaminants that may cause adverse health effects in humans, and fluoride is one of them.  
Exposure standards that are established include the maximum contaminant level goal 
(MCLG). This is a health goal set at “concentrations at which no adverse health effects are 
expected to occur and the margins of safety are judged adequate”.² A secondary maximum 
contaminant level (SMCL) is set for some contaminants, (fluoride is one of them), which is a 
guideline for “managing drinking water for aesthetic, cosmetic, or technical effects”.² The 
MCLG for fluoride is set to 4.0 mg/L, and the SMCL to 2.0 mg/L.² The standards were set in 
1986, and have been reevaluated repeatedly but not changed.3  
Besides the standards for maximum concentration of fluoride in drinking water, the European 
Food and Safety Authority (EFSA) recently published a report on tolerable upper intake (UL) 
of vitamins and minerals in Europe.106 The upper tolerable intake for fluoride is based on the 
risk for dental fluorosis (younger children), and the risk for bone fractures (older children and 
adults).10,25 The UL for adults and children aged 15 years and older is 7 mg/day, and for 
children age 9 to 14 years 5mg/day. This was based on an UL of 0.12 mg fluoride/kg body 
weight/day. The UL for younger children, age 4 to 8 years is 2.5 mg/day and 1.5 mg/day for 
children age 1 to 3 years, based on an UL of 0.1 mg fluoride/kg body weight/day. An UL for 
infants (0 to 12 months of age) is not established by the EFSA.106 A safe intake of fluoride is 
0.22 mg/kg body weight/day according to UK Department of Health (1991), but 
recommendations from the US Institute of Medicine (1997) is 0.1 mg fluoride/kg body 
weight/day.107,108 
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Estimated exposure in adults 
The estimated daily fluoride exposure in Europe from drinking water may correspond to 
amounts between 0.13 to 8.40 mg/day in adults and children aged 15 years and older.27 The 
estimated daily fluoride exposure in Europe from food and non-diary beverages correspond to 
0.120 mg/day in adults. Noteworthy is that the addition from fluoride supplemented food 
(such as table salt) is estimated in adults to be 0.25 mg per day.27 The estimated daily fluoride 
exposure from ingested toothpaste may correspond to amounts between 0.025 and 0.225 
mg/day when brushing twice a day.27 The ingested amount is depending on the fluoride 
concentration of the product, the amount used and swallowed. 
In European conditions it is estimated that the total fluoride exposure only would exceed the 
UL if around 3.0 L of drinking water with the highest fluoride concentration (~3.0 mg/L) is 
consumed daily. 
 
Estimated exposure in children  
The estimated daily fluoride exposure in Europe from drinking water may correspond to 
amounts between 0.05 to 4.5 mg/day in children aged 1 to 15.27 The estimated daily fluoride 
exposure in Europe from food and non-diary beverages correspond to 0.114 mg in older 
children, and 0.042 mg in young children. In children older than 8 years of age the estimated 
daily fluoride exposure from ingested toothpaste may correspond to amounts between 0.025 
and 0.225 mg/day when brushing twice a day, depending on the fluoride concentration of the 
product, the amount used and swallowed. In younger children, age 1 to 8 years, the estimated 
daily fluoride exposure from ingested toothpaste may correspond to amounts between 0.1 and 
0.9 mg/day when brushing twice a day,  where the worst case scenario is when “full length” 
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(0.75g) of highest concentration (1,500 mg/kg) of toothpaste is used and spitting is 
insufficient (swallowing 40%).27 
For children 6 to 12 years of age, the total fluoride exposure is estimated to exceed the UL 
only if around 1.5 L of drinking water with the highest fluoride concentration (~3.0 mg/L) is 
consumed daily. For children 1 to 6 years of age, the UL is estimated to exceeded the UL if 
around 1.0 L of drinking water with fluoride concentration of ~0.8 mg/L is consumed daily, 
in combination with high consumption of toothpaste.27 
 
Estimated exposure in infants 
During the first months of life the main food source for infants is breast milk or formula. 
Therefore, the fluoride exposure mainly depends on if they are fully or partly breast fed. As 
mentioned before, the amount of fluoride found in human breast milk is low (~6.0 µg/L), this 
correspond to less than 0.001 mg/kg/day.59 But if the child is formula-fed, the fluoride 
exposure is dependent on the water used, the brand, and the amount fed. The estimated daily 
fluoride exposure in formula fed infants may correspond to amounts between 0.02 and 0.47 
mg/kg body weight/day.27 
In infants being formula-fed, the risk for excess fluoride exposure is evident if the drinking 
water exceed 0.8 mg/L. 
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3 AIMS 
 
The general aim of this thesis is to investigate possible adverse health effects from natural 
drinking water fluoride exposure, focusing on three different health outcomes: bone fracture, 
myocardial infarction, and malignant osteosarcoma. 
 
Study I Our aim was to investigate the association between fluoride exposure and risk 
of hip fracture in a cohort of individuals chronically exposed to natural fluoride 
in the drinking water. 
 
Study II Our aim was to investigate the association between fluoride exposure and risk 
of myocardial infarction in a cohort of individuals chronically exposed to 
natural fluoride in the drinking water. 
 
Study III Our aim was to investigate the association between fluoride exposure and risk 
of osteosarcoma. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 14 
4 METHODS 
 
4.1 STUDY SETTING 
 
In all studies in this thesis we used data from Swedish population-based national registries. 
All Swedish residents are assigned a unique personal identification number, at birth or upon 
immigration that allows linkage among national registries.109 The Swedish health care system 
is public and hospital referrals are based on geographical residency rather than financial 
capacity or health insurance. 
 
4.2 DATA SOURCES 
 
4.2.1 The Total Population Register 
The Total Population Register, is maintained by Statistics Sweden and updated daily. The 
register contains individual data such as personal identity number (or national registration 
number), age, sex, place of birth, citizenship, civil status, highest educational level (since 
1985), date of death, and other demographic information of all residents in Sweden since 
1961.110 Migrations (both domestic and international) have been registered since 1969. 
 
4.2.2 The Cause of Death Register 
The Cause of Death Resister, which is managed by the National Board of Health and 
Welfare, contains data on the date of death and primary and contributing causes of death for 
all Swedish residents since 1961, regardless if the death occurred in Sweden or abroad.111 
There are no missing deaths since 1997, but in up to 0.5% of the deaths the cause of death is 
unknown. 
 
4.2.3 The National Patient Register 
The National Patient Register, which is managed by the National Board of Health and 
Welfare, contains data on hospitalizations (inpatient) from 1964. Initially the register 
contained data from only six Swedish counties, but gradually expanded and reached full 
national coverage in 1987 (Table 2).112 The outpatient register was initiated in 2001 and 
includes data on diagnoses in non-primary outpatient care, coded according to ICD version 
10. The coverage in the National Patient Register is close to 100% for the inpatient part, and 
approximately 87% for the outpatient visits (missing primarily from private care givers).113,114 
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The National Patient Register contains the patient’s personal identification number, the date 
of hospital admission and discharge, and one primary discharge diagnosis, and up to seven 
additional diagnoses coded according to the International Classification of Diseases (ICD-7 
until 1968, ICD-8 from 1968 through 1986, ICD-9 from 1987 to 1996, and ICD-10 
thereafter). 
 
 
 16 
4.2.4 The Swedish Cancer Register 
The Swedish Cancer Register established in 1958, is managed by the National Board of 
Health and Welfare.115 The register is a nationwide register based on mandatory reports of 
cancer diagnoses from healthcare providers in Sweden. The completeness and accuracy of the 
Swedish Cancer Register is generally high: over 96% of patients with a cancer diagnose are 
registered.116 
 
4.3 STUDY DESIGN 
 
Study I and II are population-based retrospective cohort studies (Table 3). In a retrospective 
cohort study, data collected in the past are used to identify the population of interest and the 
time period where they were at risk occurred before the study was conducted.117 Typically, a 
cohort comprise of individuals classified according to exposure status, and then followed over 
time, and the occurrence of one or more specific outcomes (diseases) are measured. The aim 
is to compare the ratio between the disease rate of the exposed population and that of the 
unexposed population (or a subgroup of the individuals in the cohort). 
 Study III is a population-based case-control study (Table 3), where cases are identified and 
control subjects are sampled from the entire source population that gave rise to the cases.117 
The exposure status for cases and controls are determined. The aim is to yield a measure of 
association between an exposure and the outcome of interest (disease). An odds ratio is 
calculated, which is the ratio of the odds of an exposure in the case population to the odds of 
an exposure in control population. Case-control studies is preferred when studying a rare 
disease or outcome. 
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4.3.1 Study I and II 
Our study population were identified in the Total Population Register, and consisted of 
individuals born in Sweden between January 1st, 1900 and December 31st, 1919, alive and 
living in their birth parish at the time of start of follow-up. The follow-up started from the 
date the county of residence (birth) had full coverage in the National Patient Register, (i.e. 
earliest start January 1st, 1964 and latest start January 1st, 1987). Out of 1,951,244 individuals 
born between January 1st, 1900 and December 31st, 1919, 474,217 individuals were alive and 
living in their birth parish at the time of start of follow-up.  
 
Study I 
In study I the outcome of interest was first hip fracture (International Classification of 
Diseases (ICD)-7 to 9 codes: most diagnoses starting with 820; and ICD-10 codes: S720, 
S721, or S722). 940 individuals in the baseline cohort were diagnosed with a hip fracture 
prior to start of follow-up and were subsequently excluded. Additionally, 20,453 individuals 
had missing exposure data and were excluded from the analyses. Thus, the number of eligible 
individuals was 452,824.  
Hip fracture was the failure event, and individuals with no hip fracture were censored at 
death, migration from the municipality of birth, or at the end of follow-up (December 31st, 
2006), whichever occurred first. All eligible study subjects were followed through linkage to 
the Total Population Register to ascertain domestic movement, emigration, or death during 
follow-up. Hip fractures were determined from the National Patient Register and the Cause of 
Death Resister by the ICD-codes. Additional codes for low-trauma osteoporotic fractures 
were retrieved, i.e. a fracture occurring after a fall from less than standing height (ICD7: 
E903.9; ICD8-9: E885 and E886; and ICD-10: w00, w01, w03 and w18). All primary and 
additional discharge diagnoses, and primary and contributing causes of death diagnoses were 
examined for the first occurrence of the outcome of interest. High-energy trauma fractures 
were not included in the study. 
 
Study II 
In study II the outcome of interest was first myocardial infarction (International Classification 
of Diseases (ICD)-7 codes: 420.10:420.17, ICD-8 to 9 code: 410; and ICD-10 codes: I21-
I22). 4341 individuals in the baseline cohort were diagnosed with a myocardial infarction 
prior to start of follow-up and were subsequently excluded. Additionally, 14,257 individuals 
had missing exposure data and were excluded from the analyses. Thus, the number of eligible 
individuals was 455,619. 
Myocardial infarction was the failure event, and individuals with no myocardial infarction 
were censored at death, migration from the municipality of birth, or at the end of follow-up 
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(December 31st, 2006), whichever occurred first. All eligible study subjects were followed 
through linkage to the Total Population Register to ascertain domestic movement, emigration, 
or death during follow-up. Myocardial infarctions were determined from the National Patient 
Register and the Cause of Death Resister by the ICD-codes. All primary and additional 
discharge diagnoses, and primary and contributing causes of death diagnoses were examined 
for the first occurrence of the outcome of interest. Information on whether the myocardial 
infarction was fatal or not (death within 28 days from hospitalization / the acute event) was 
also retrieved from the Cause of Death Register. 
 
4.3.2 Study III 
A case was defined as a histologically verified diagnosis of primary, malignant osteosarcoma 
(ICD-7: 196, PAD: 766). All individuals diagnosed with osteosarcoma in Sweden, and born 
January 1st, 1969 and onwards, were identified in the Swedish Cancer Register. 363 eligible 
osteosarcoma cases were retrieved, only tumours of bone topography were included. Control 
subjects were matched to cases (5:1) on birth year and sex. 1,815 controls were randomly 
drawn from the Total Population Register at the year before the corresponding (matched) 
case was diagnosed. A control had to be alive and without a malignant bone cancer at the 
time of selection. The same control could be drawn as a control more than once, and cases 
were eligible to be drawn as controls. 
Denominator data were retrieved from the Total Population Register provided by Statistics 
Sweden. Data on highest known educational level, domestic movements and migrations 
(dates and locations) were collected for all cases and controls, from birth upon index date 
(date of cancer diagnosis). For cases and controls all inpatient and outpatient data from birth 
upon index date were retrieved from The National Patient Register, and all cancer diagnosis 
were retrieved from the Swedish Cancer Register, from birth upon index date. 
 
4.4 EXPOSURE ASSESSMENT 
 
Information on community drinking water content was provided from the Swedish Water & 
Wastewater Association (SWWA) (available annually from 1960 to 1968, and from 1969 to 
1999 every fifth year)29, and from The Geology Survey of Sweden (SGU) (annually from 
1999)118, which collects and evaluates data from all Swedish water companies. Information 
about the water treatment plant (geographical location, type of water supply, type of 
distribution, produced water (m³/day), number of affiliated households, etc.), and a number of 
different physical and chemical water properties for each water treatment plant was available. 
Fluoride exposure was limited to the exposure from community water supplies. Drinking 
water data from private wells were not available, thus causing missing exposure data for 
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some of the individuals in the cohort. We do not have information on individual water intake, 
intake from other dietary sources of fluoride, or the use of fluoride containing dental hygiene 
products. 
In Study I and II each water treatment plant was assigned a mean value of fluoride level 
(mg/L) in the distributed drinking water. The fluoride level in the municipalities of our study 
population ranged from <0.1 up to about 2.7 mg/L. The variation of fluoride levels in the 
investigated municipalities was small during the study period. A variation of more than ±0.2 
mg/L was detected for only eight percent of the study population. Information on residence 
from parish records was used to address a community water supplier for each individual in 
the cohort. The fluoride distribution was divided into concentration categories relevant for 
drinking water fluoride concentrations for the prevention of dental caries: very low <0.3 
mg/L, low 0.3 - <0.7 mg/L, medium 0.7 - <1.5 mg/L and high ≥1.5 mg/L.7 
In Study I, 20,453, and Study II, 14,257, cohort subjects had missing exposure data, due to no 
community water supplier in the municipality of residence, or no measurement report. 
Moreover in Study II the fluoride distribution was also divided into quantiles (octiles), eight 
equal-size groups. Additionally each water treatment plant was assigned a mean value of 
water hardness in the distributed drinking water. The total water hardness was measured in 
German hardness degrees, °dH (1 °dH = 7.1 mg calcium/100 ml water). The water hardness 
ranged between 2 and 147 mg/L in our study, and for about 2% of the cohort (n=9896) data 
on hardness was missing. The hardness distribution was divided into concentration categories 
as follows: very soft ≤2 °dH (≤15 mg/L), soft 2.1 – 4.9 °dH (15 – 35 mg/L), medium hard 5.0 
– 9.8 °dH (36 – 70 mg/L), and hard ≥9.9 °dH (≥71 mg/L). 
In Study III each case and control were assigned a mean drinking water fluoride level for 
each year from birth upon index date (date for osteosarcoma diagnosis). The fluoride level in 
the municipalities of our study population ranged from 0.03 up to about 2.75 mg/L. Fluoride 
was modelled as a continuous variable as well as an ordinal variable, dividing the distribution 
into quartiles and concentration categories relevant for drinking water fluoride concentration 
for the prevention of dental caries.7 For 8.6% (n=188) of the population, residence 
information was missing at some time between birth and index date, which led to missing 
fluoride exposure data. Missing residence information was either due to emigration (8 
controls), or born abroad (32 cases and 148 controls), about 35% had missing residence 
information of more than 50% of the years from birth upon index date.  
 
4.4.1 Missing data 
In this thesis missing exposure data was handled in two different ways. In Study I - III, 
individuals in the cohort having missing drinking water fluoride, or hardness levels were 
excluded from the analysis. We only focused on the individuals in the cohort having valid 
exposure data. 
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In Study III, a second approach was considered, were we assigned exposure values based on 
the individual’s own exposure data during the study period.119 Impute of either the lowest 
recorded exposure value, or the highest recorded exposure value. We additionally performed 
different models including only individuals having less than 25%, or less than 50% of the 
years missing from birth upon index date. 
 
4.5 STATISTICAL METHODS 
 
4.5.1 General aspects 
We used the Statistical Analysis System (SAS) package, version 9.3 (Study I-II) and version 
9.4 (Study III), for all statistical analyses. 
 
4.5.2 Baseline characteristics 
In Study I and II the categorical variables, presented as proportions, were assessed with Chi-
square test, and the continuous variables, presented as median values, were compared with 
the non-parametric Kruskal-Wallis test. In Study III the characteristics of cases and controls 
were assessed by univariate conditional logistic regression, to determine any significant 
differences between the two groups. 
 
4.5.3 Cox Proportional Hazards Regression Model 
The Cox proportional Hazards Regression Model is commonly used in time-to-event 
analysis.117 The Cox model is used to model the relationship between a set of covariates (one 
or more) and the hazard rate. The output is given as the hazard ratio (HR). The hazard is the 
risk of an event (outcome) in a specific time interval, assuming survival to that time. A 
hazard ratio of 1 correspond to equal risk compared to the comparator group. A hazard ratio 
below 1 correspond to a decreased risk, whereas a hazard ratio above 1 correspond to an 
increased risk. If the confidence intervals include 1 the hazard ratio is not statistically 
significant.  
The basic aim of the Cox regression analyses in Study I was to investigate the association 
between fluoride exposure and hip fracture. Hip fracture was the failure event, and 
individuals with no hip fracture were censored at migration from the municipality of birth 
(n=12,562), death (n=370,564), or end of follow-up, December 31st, 2006 (n=29,378), 
whichever occurred first. Person-years were calculated for each individual in the cohort. 
Time was modeled from the date the county of residence had full coverage in the National 
Patient Register to the date of the failure event or the date of censoring. Crude hazard ratios 
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included sex, and attained age in 5-year categories. We adjusted for calendar period for study 
entry in 5-year categories, and geographical area of residence (county). Fluoride exposure 
was analyzed as a categorical variable (4 categories), we used the lowest exposure group (i.e. 
the largest exposure group) as reference. Analyses were stratified by sex, and attained age 
(<70 years, 70 - <80 years and ≥80 years of age). To test whether the effect of fluoride was 
modified by sex or attained age, Wald’s heterogeneity test was performed. Additionally, we 
restricted the analyses to only the low trauma osteoporotic fractures in the cohort. 
The basic aim of the Cox regression analyses in Study II was to investigate the association 
between fluoride exposure and myocardial infarction. Myocardial infarction was the failure 
event, and individuals with no myocardial infarction were censored at migration from the 
municipality of birth (n=11.670), death (n=214,970), or end of follow-up, December 31st, 
2006 (n=24,450), whichever occurred first. Person-years were calculated for each individual 
in the cohort. Time was modeled from the date the county of residence had full coverage in 
the National Patient Register to the date of the failure event or the date of censoring. Crude 
hazard ratios included sex, and attained age in 1- and 5-year categories. We adjusted for 
calendar period for study entry in 1- and 5-year categories, geographical area of residence 
(county), and total water hardness (4 categories). Fluoride exposure was analyzed as a 
categorical variable (4 categories and quantiles), we used the lowest exposure group (i.e. the 
largest exposure group) as reference. Fluoride exposure was additionally analyzed as a 
continuous variable, implying a log-linear association. To test for a possible threshold effect a 
cut point of 1.0 mg/L was set. Analyses were stratified by sex, attained age (<70 years, 70 - 
<80 years and ≥80 years of age), geographical area of residence (south, middle, north), and 
time period (1964-1984, 1985-2006). To test whether the effect of fluoride was modified by 
sex, attained age, geographical area, or time period, Wald’s heterogeneity test was performed. 
To avoid prevalent cases that could affect the result, a sensitivity analysis excluding the first 
year of follow-up were performed. Additionally, we stratified the analyses by fatal and non-
fatal myocardial infarctions. 
 
4.5.4 Logistic regression 
Logistic regression is used to model the association between the dependent variable (a binary 
outcome, e.g. presence or absence of disease) and the independent variables (categorical 
and/or continuous).117 The method of choice in case-control studies. The logistic regression 
model estimates odds ratios (OR), and is defined as the cases’ odds of having been exposed to 
a risk factor, divided by the controls’ odds of having been exposed to the same risk factor. 
Conditional logistic regression is often used in matched case-control studies, where each 
individual is only compared with the matched individual/individuals.117 Though, the effect of 
the matching variables is minimized. Unconditional multivariate logistic regression could 
also be used to calculate odds ratios, where all the matching variables are included in the 
analysis, but then an overestimate of the odds ratio will be obtained. 
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The basic aim of the conditional logistic regression analyses in Study III was to investigate 
the association between fluoride exposure and osteosarcoma in a matched case-control 
design. The dependent variable identifying cases (osteosarcoma diagnosis), and measures of 
fluoride exposure were the primary independent variables (examined both as a continuous as 
well as a categorical variable). Adjusted logistic regression models included education, other 
cancer and history of bone fractures prior to index date. Fluoride exposure was analyzed as a 
categorical variable (4 categories and quartiles), we used the lowest exposure group as 
reference. Fluoride exposure was additionally analyzed as a continuous variable, implying a 
log-linear association. To test for a possible threshold effect a cut point of 0.7 mg/L was set. 
The analyses was further stratified by age, sex, and time period for exposure. Additionally we 
performed sensitivity analyses where we used different handling of missing exposure data, 
and where we excluded individuals diagnosed with other cancer prior to index date.  
 
4.6 ETHICAL CONSIDERATIONS 
 
All studies (I-III) are register-based studies, based on information collected from patients in a 
standardized manner. Informed consent is not required for the inclusion of data in the national 
registers, but to ensure that the potential benefits for the population outweigh the risk for the 
individual, an ethical board have to evaluate the importance and soundness of the research120, 
and an ethical approval can endorse the access to national register data for research purpose. 
All studies (I-III) were approved by the Research Ethics Committee of the Karolinska 
Institutet, Stockholm, Sweden on the 12th of October, 2006 (dnr 2006/1052-31), and additions 
were approved by the same committee on the 9th of March, 2011 (dnr 2011/177-32). All data 
in this project were handled and analyzed at an aggregated level to protect patient privacy. 
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5 RESULTS 
 
5.1 STUDY I 
 
There was no significant association between drinking water fluoride exposure and hip 
fracture. Compared to the lowest exposure group (named very low) the hazard ratios were 
HR 0.97; 95% CI 0.94-0.99 for the low group, HR 0.97; 95% CI 0.94-1.00 for the medium 
group, and HR 0.98; 95% CI 0.93-1.04 for the high group. Adjusting for potential 
confounding factors such as age, sex, calendar period and geographical area did not change 
the risk estimates. Analysis were stratified by age (<70 years, 70 - <80 years, and ≥80 years) 
and sex. The risk estimates were statistically significantly different between age groups (p 
<0.001), and the results suggest a protective effect of fluoride in the two younger age groups. 
Though, the majority of fractures occurred above the age of 80 years. No difference was seen 
between men and women (p <0.540). 
Additional analyses, looking specifically at hip fractures coded as low-trauma fractures 
(regarded as osteoporotic fractures), was performed in our population. No association was 
found between drinking water fluoride exposure and low-trauma fractures, the HRs did not 
differ from the overall HRs. Adjusting for potential confounding factors such as age, sex, 
calendar period and geographical area did not change the risk estimates. Analysis were 
stratified by age (<70 years, 70 - <80 years, and ≥80 years) and sex. The risk estimates were 
statistically significantly different between age groups (p <0.001), and the results suggest a 
protective effect of fluoride in the two younger age groups. Though, the majority of fractures 
occurred above the age of 80 years. No difference was seen between men and women (p 
<0.093). 
 
5.2 STUDY II 
 
There was no statistically significant association between drinking water fluoride exposure 
and myocardial infarction. When the exposure variable was analyzed as a categorical variable 
(4 levels), compared to the lowest exposure group (named very low) the hazard ratios were as 
follows: HR 0.99; 95% CI 0.98-1.00 for the low group, HR 1.01; 95% CI 0.99-1.03 for the 
medium group, and HR 0.98; 95% CI 0.96-1.01 for the high group. Adjusting for potential 
confounding factors such as attained age (1- and 5-year categories), sex, calendar period for 
study entry, geographical area and total water hardness (4 levels) did not change the risk 
estimates. No difference was seen either between men and women (p=0.470), nor between 
age groups (<65 years of age and ≥65 years of age) (p=0.437) or time periods (1964-1984 
and 1985-2006) (p=0.058).  
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A geographical variation in the risk pattern was seen (p<0.001), the results suggest an 
association between fluoride exposure and myocardial infarction in the north of Sweden. 
Compared to the lowest exposure group (named very low) the hazard ratios were as follows: 
HR 1.04; 95% CI 1.00-1.07 for the low group, HR 1.12; 95% CI 1.07-1.16 for the medium 
group, and HR 1.09; 95% CI 1.02-1.17 for the high group. 
Additional separate analyses was performed, looking at fatal and non-fatal myocardial 
infarctions. No association was found. Adjusting for potential confounding factors such as 
attained age (1- and 5-year categories), sex, calendar period for study entry, geographical area 
and total water hardness (4 levels) did not change the risk estimates. 
 
5.3 STUDY III 
 
Overall, no statistically significant association was found between fluoride exposure and 
osteosarcoma. Treating the exposure variable as a continuous variable, the odds ratio (OR) 
for osteosarcoma for 1 mg/L increase in drinking water fluoride level was 0.99 (95% CI 0.67-
1.44). Adjustments were made for age, sex, level of education, other cancer or history of bone 
fractures prior to index date. Analyses restricted to individuals younger than 20 years of age 
did not change the result. No evidence of a threshold effect was seen, OR 1.04 (95% CI 0.76-
1.43) with cut-off at 0.7mg/L. 
Separate analyses were performed at specific time windows; cumulative fluoride exposure up 
to ages 2, 6, 12 and 16 years. No association was found. Additional analyses were performed 
for specific time periods prior to index date; 1, 2, 3, 4 and 5 years. No association was found. 
All analyses were also stratified by sex and age (younger than 20 years of age). No 
association was found. 
Finally. Sensitivity analyses were performed. Missing values for fluoride was assigned 
(impute), the result did not change. Nor did the result change when excluding individuals 
diagnosed with other cancer prior to index date.  
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6 GENERAL DISCUSSION 
 
6.1 METHODOLOGICAL CONSIDERATIONS 
 
6.1.1 Study design 
Randomized clinical trials are considered the gold standard in evidence based medicine, 
whereas observational studies often are considered inferior.121 However, observational studies 
are justified in medical research for several reasons.122,123 Most importantly, experimental 
studies are not always possible, and may be inappropriate or unreasonable because of ethical 
and legal reasons. Cohort and case-control studies are the two main types of epidemiological 
studies. The choice of study design is generally a compromise between efficiency and 
validity, but a suboptimal study design may affect the validity and introduce bias that are 
difficult to remove in the statistical analysis. Yet in any research the choice of an eligible 
method for statistical analysis is essential, but the choice of an appropriate study design is 
many times even more important as the causal interpretation of the results often is dependent 
on the design of the study.117 
 
6.1.1.1 Cohort studies (I-II) 
Cohort studies are suitable for studies of multiple outcomes or rare exposures, and considered 
to have a higher validity than case-control studies.117 However, for cohort studies to be 
efficient, a reasonable number of study subjects have to be followed to be able to study the 
disease of interest. They are considered time consuming and expensive, particularly in large 
prospective cohort studies and studies of rare diseases, but this is not the case in historical 
cohort studies based on national registers. Since the data is already collected and registered, 
the time consumption is substantially reduced and the costs are not dependent of the study 
size. Prospectively collected data, as in Swedish national registers, minimize the risk of recall 
bias, and additionally, when the collection of data is made without knowledge of future 
studies, the risk of biased registrations is limited. However, the disadvantage with historical 
data is that there might be a lack of information that limit access to potential confounding 
factors and exposure data.117 
In study I and II we aimed to identify a population that had been living in the same 
geographical area (parish) since birth, and thereby have had the same source for exposure 
(drinking water). Since the outcomes of interest (hip fracture and myocardial infarction) 
occur relatively late in life, the study population had to be old enough for the outcome of 
interest. Therefore our study population was born between January 1st 1900 and December 
31st 1919.  
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6.1.1.2 Case-control studies (III) 
When studying rare outcomes, a case-control design may be the most suitable approach.117 A 
cohort design would be inefficient and time consuming. In contrast to cohort studies, only a 
sample of the source population is collected in case-control studies, which generates risk for 
bias. The validity of the study depends on the comparability of the cases and controls. The 
source population is the set of individuals at risk for developing the outcome of interest, and 
both the cases and the corresponding controls should be representative of the same 
population.124 
Controls can be matched on confounders to improve the efficiency, but only strong risk 
factors should be considered for matching. However, the matching does not control for 
confounding, the statistical analysis must adjust for the matching factors.117 If the control 
subjects are too closely matched to their corresponding case they may not be representative of 
the general population and thereby affect the generalizability of the results. Additionally, if 
the matching variable is strongly associated with the exposure there is a risk for overmatching 
which may cause an underestimation of the true difference. 
In study III we aimed to identify all individuals with an osteosarcoma diagnosis, and the 
individuals with osteosarcoma were matched to controls within the same source population. 
To assure complete residence history (i.e. complete history of exposure) the individuals had 
to be born 1st of January 1969 and onwards, since register data on domestic movements and 
migrations are available since the year 1969. 
  
6.1.2 Internal validity 
Internal validity is the extent to which the study actually measure what it is intended to do.125 
The internal validity is threatened by two types of error, systematic error (bias) and random 
error.   
 
6.1.2.1 Selection bias 
Selection bias is a systematic error resulting from the procedures used when selecting study 
subjects and from factors affecting the study participation.117 In all present studies the study 
populations were retrieved from population based registers which are complete and 
continuously updated. Due to the population-based design, the probability of being sampled 
is the same for all Swedish residents and limits the selection bias. Though, the criteria for our 
study population in study I and II were restricted to individuals living in their municipality of 
birth by the time of start of follow-up, i.e. non-movers. We cannot rule out that non-movers 
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might differ from the general population, but that the exposure (drinking water fluoride) 
would be associated with domestic movements or emigrations seems highly unlikely. 
In our case-control study (study III) the control subjects were sampled from the Total 
Population Register were all Swedish residents are included, hence giving all residents the 
same probability of being sampled. 
 
6.1.2.2 Recall bias 
Recall bias occur whenever self-reported exposure-information is used. In the present studies, 
recall bias was not a problem since information on exposure was retrieved from pre-existing 
registers and not based on the memory of the study participants.  
 
6.1.2.3 Information bias 
Information bias, or misclassification, is a measurement error of the exposure or outcome. 
Differential misclassification (when the measurement error depends on other variables) may 
introduce an over- or underestimation of the true association, whereas a non-differential 
misclassification (when the measurement error is independent of other variables) tend to 
affect any association towards the null.117 
 
Misclassification of outcome 
The overall validity in the Swedish hospital discharge register is high, and for most diagnoses 
the positive predictive values are 85-95%.113 The positive predictive value for both hip 
fracture (study I) and myocardial infarction (study II) is close to 100%. The completeness and 
accuracy of the cancer register is generally high, and over 96% of patients with a cancer 
diagnose is registered.116 Therefore the risk of misclassification of outcome is assumed to be 
small. 
 
Misclassification of exposure 
We only assessed fluoride exposure from drinking water, no information on other dietary 
source for fluoride (such as bottled water, food and dental hygiene products) was available. 
Drinking water is a major source for fluoride and is estimated to account for 66 to 80% of the 
total fluoride intake.7 In Sweden the intake from food is generally low, less than 1 to 6% of 
the total fluoride intake27,69, and the consumption of bottled water is limited due to the high 
tap water quality. The consumption of bottled water was 0.03 L/person/day in 1993 and has 
since then increased to 0.07 L/person/day in 2014.126 However, the ingestion of fluoride from 
dental hygiene products might account for an important part of the total fluoride load in 
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younger age groups, depending on the fluoride concentration of the product and the amount 
used and swallowed.27,34 This measurement error might underestimate any true effect. 
Additionally, a non-differential misclassification of exposure cannot be ruled out. Individual 
fluoride exposure levels were assigned through linkage of parish records to distribution areas 
of community water works. Moreover, we lack information on actual consumption of tap 
water and individuals could be categorized as exposed when in fact they might be unexposed 
and vice versa. But according to data from a national health survey in 1999, less than 4% of 
the Swedish population do not drink tap water at home.127 All measurement of fluoride levels 
at each water work is subject to error in the laboratory and when typed into the register. 
Though, any non-differential misclassification of exposure would be independent of disease 
and mainly affect the results toward the null. 
 
6.1.2.4 Confounding 
Confounding means a mixing of effects. By definition, a confounding factor is associated 
with the exposure and the outcome, must have an effect, and must be imbalanced between the 
exposure groups compared.117 The true association is clouded when confounding is present. 
Confounding can be handled in many ways, randomization, matching, stratification, 
restriction and in regression models.117 
In the present studies we used different methods of handling confounding. In studies I and II 
potential confounders such as age, sex, calendar period and county of residence were 
included in the regression models. In study II drinking water hardness was also included in 
the regression models. 
In study III, control subjects were matched to the index person by age at diagnosis and sex. 
Conditional logistic regression was applied to handle the matching variables. Other potential 
confounders such as educational level, other cancer and history of bone fractures were 
included in the regression models. 
In studies I and II we also performed additional analysis with stratification for sex, age, 
geographical area, calendar period for diagnosis. To adjust for the potential confounding 
effect of hip fracture type in study I, we restricted the analysis to individuals diagnosed with a 
low-trauma fracture. Additionally, to adjust for the potential confounding effect of fatal and 
non-fatal myocardial infarction in study II, we restricted the analysis to individuals diagnosed 
with a fatal or non-fata myocardial infarction. In the matched case control study (study III), 
we also stratified on sex, different age groups and exposure groups. To adjust for the potential 
confounding effect of other cancer in study III, we restricted the analysis to individuals 
without previous other cancer disease. Additionally, to adjust for the potential confounding 
effect of bone fractures in study III, we restricted the analysis to individuals without previous 
bone fracture. 
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In our present studies we did not have information on a number of other potential risk factors 
such as smoking, alcohol use, body mass index, nutrition, socioeconomic factors etc. The 
possibility that unmeasured confounding may have influenced the observed findings should 
be taken into consideration. In study I it is not possible to rule out that the findings of a 
protective effect of fluoride in the two younger age groups (≤80 years of age) are because of 
confounding by for example, other dietary factors, smoking, body mass index, alcohol use, 
and hormone-replacement therapy. In study II, the observed geographical variations in 
myocardial infarction risk could be explained by other confounding such as socioeconomic 
factors, hereditary factors, lifestyle, climate, and other compounds in the drinking water. 
Additionally, in study III cofounding by for example socioeconomic factors, body height, 
radiation therapy, and genetic factors may have affected the findings and cannot be ruled out.   
 
6.1.2.5 Random error 
Random error is referred to as chance, and defined as fluctuations in the estimates that cannot 
promptly be explained.117 A finding, both null and positive results can be due to chance, and 
confidence intervals and p-values roughly estimates the role of chance. The precision is high 
when the confidence intervals are narrow and the p-value is small, and can be improved by an 
increased sample size. However, a high degree of precision is not equal to a high degree of 
validity. Therefore, regardless of sample size and precision, Hill’s criteria of causality must 
be considered (for example strength of the association, consistency, biologic plausibility, 
dose-response effect).117 
The large register based cohort in study I and II increased the precision, and resulted in 
narrow confidence intervals but the main results in the studies were non-significant 
(confidence intervals including 1). There cannot be ruled out that the observed lack of 
association is due to chance. In study III the outcome of interest (osteosarcoma) was rare, 
causing wider confidence intervals and non-significant results. This could possibly be due to 
lack of power. Furthermore, when performing many sub-analyses the possibility of chance 
findings increase. Therefore, the findings from sub-analyses in study I-III must be interpreted 
with caution. 
 
6.1.3 External validity 
External validity (generalizability) refers to how relevant findings from the population 
studied are for populations other than the one studied.125 Since study I and II were 
population-based and nation-wide, they are generalizable to the Swedish population. Study III 
was population-based and nation-wide, and the generalizability in study III is also considered 
high. Even though the generalizability of the findings (risk estimates) in our studies is 
restricted to a Swedish population, the findings can provide information for similar 
populations and settings in other countries. 
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6.2 FINDINGS AND IMPLICATIONS 
 
6.2.1 Study I 
The association between lower fluoride intakes, levels associated with oral health prevention, 
and bone fracture risk has been assessed in several studies, but the results are 
inconclusive.57,68,69 We hypothesized that there would be an association between fluoride 
level in the drinking water and the risk of hip fracture. We found no such association between 
fluoride exposure levels ranging between <0.1 and 2.7 mg/L and risk of hip fracture, after 
adjustments for age, sex, geographical area and calendar period for start of follow-up. Nor did 
we see an association between fluoride level and the risk of low-trauma osteoporotic fracture. 
Stratified analyses suggested that fluoride exposure in individuals younger than 80 years of 
age seemed to be associated with a decreased risk for hip fracture, and no gender difference 
was detected. However, no clear exposure-response effect was observed. We cannot rule out 
that unmeasured confounding may have influenced the observed results. 
We had no data on other dietary source for fluoride, or data on the use of dental hygiene 
products containing fluoride. Though, the main source for ingested fluoride is drinking water, 
and fluoride intake from other sources is limited in our study population. However, we cannot 
rule out that non differential misclassification of exposure may have affected the results. 
Our findings are in line with recent published studies of drinking water fluoride levels around 
1.0 mg/L and hip fracture risk, where no association was found.128-130 Others have found 
evidence of a decreased risk.131,132 A previous cohort study133 using a similar study design as 
ours, found no association between drinking water fluoride exposure and hip fracture risk 
among study subjects older than 65 years of age. But, in contrast to our findings of no gender 
difference, they report an elevated hip fracture risk (RR, 1.44; 95% CI 1.12-1.86) for younger 
women (<65 years of age) whereas the association for men was the opposite (RR, 0.75; 95% 
CI 0.51-1.12). However, an important difference between that study and ours is that the 
cohort consisted of only rural individuals, and the risk patter for hip fracture may be different 
for rural populations134,135, and comparisons are difficult to make. 
Most of the previous epidemiological evidence that relate drinking water fluoride exposure to 
hip fracture risk are derived from comparisons of different geographic regions.136-141 The 
findings are though difficult to interpret because of analyses based on group data and not on 
individual data, and the inability to control for confounding factors may distort the true 
association (ecological fallacy).142 Moreover, excessive fluoride exposure are shown to have 
major impact on bone fracture risk2, but the hazard found in such studies cannot be compared 
to the much lower exposures that are investigated in our study. 
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6.2.2 Study II 
Studies conducted in fluoride endemic areas have demonstrated an adverse effect from 
fluoride exposure on the cardiovascular system90,91,93,94, whereas the epidemiological 
evidence addressing lower exposure levels is limited. We aimed to investigate the association 
between drinking water fluoride exposure and the risk of myocardial infarction, and we found 
no clear evidence of association. Adjustments were made for age, sex, geographical area, 
calendar period for start of follow-up and drinking water hardness. By restricting the analyses 
to non-fatal respective fatal myocardial infarction, the findings did not alter. No age, gender, 
or difference in time period was detected.  
As in study I, we had no data on other dietary source for fluoride, or data on the use of dental 
hygiene products containing fluoride. Though, the main source for ingested fluoride is 
drinking water, and fluoride intake from other sources is limited in our study population. 
However, we cannot rule out that non differential misclassification of exposure may have 
affected the results. Additionally, various trace elements in the drinking water have been 
investigate in the pathogenesis of cardiovascular disease.143 We were able to adjust for total 
water hardness, though adjustments did not alter the results. But data on other geochemical 
compounds in the drinking water were not available, and we cannot rule out that some 
minerals could covariate with fluoride and be a source for confounding. 
Our main results are in concert with two large cohort studies144,145, where no association was 
found between drinking water fluoride exposure and ischemic heart disease. Though, the 
outcome was death from ischemic heart disease (i.e. myocardial infarction) in the previous 
cohort studies, in contrast to our study where both fatal and non-fatal MI was investigated. 
Hence, no difference was seen between fatal and non-fatal myocardial infarction in the 
present study. 
Other epidemiological studies have demonstrated an inverse relationship, where very low 
drinking water fluoride levels were associated with an increased risk of myocardial 
infarction89,96-98. The potential protective effect found on myocardial infarction, has been 
attributed an indirect association, via oral health improvement98, but causality cannot be 
asserted due to bias. Additionally, some of the studies suffer from methodological limitations 
such as hospital based studies89, small sample size89, or low external validity due to only 
men89,96,97 or only rural population98. We could not confirm these findings. On the contrary, 
some evidence of a positive association was found between fluoride exposure and myocardial 
infarction risk in the northern part of Sweden. This association may in part be explained by 
unmeasured confounding. Moreover, only a small effect size is detected, and in combination 
with the large sample size and total number of events, we consider that this finding is unlikely 
to be of significance.  
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6.2.3 Study III 
There is no clear association between fluoride exposure and osteosarcoma risk. According to 
two systematic reviews, the included studies suffer from methodological deficiencies and 
lack of homogeneity.57,69 Specific time windows for exposure has been suggested to be of 
importance for osteosarcoma development. We hypothesized that there would be an 
association between fluoride level in the drinking water and the risk of osteosarcoma. No 
association was found between drinking water fluoride exposure and osteosarcoma risk. 
Adjustments were made for age, sex, education, other cancer, and bone fractures. Different 
exposure-times before osteosarcoma diagnosis was studied, as well as different exposure-
ages, to evaluate potential important time-windows for exposure. 
Our evaluation of different age- and time-specific exposure levels are in contrast with the 
previous case-control study by Bassin et al.71  That study found an increased osteosarcoma 
risk in young boys (<20 years of age) exposed to drinking water fluoride at 6 to 8 years of 
age, with a peak at 7 years of age, aOR 5.46; 95% CI 1.50-19.90. No consistent association 
was found among young girls. The study suffered, however, limitations such as selection bias 
because of difference in referral patterns between cases and controls, and potential recall bias 
due to retrospective collection of information true interviews. An important difference in our 
study is the use of information collected in a standardized manner (population-based 
registries), limiting the possibility of selection and recall bias. A second investigation was 
conducted based on data from the study by Bassin et al.71 and additional set of patients from 
the same population source.73 In that study the bone fluoride concentrations was investigated, 
in contrast to fluoride levels in the drinking water. The findings from Bassin et al.71 could not 
be confirmed. The use of bone fluoride concentration is an advantage, yet the study suffered 
from selection bias when controls where other bone cancer patients, i.e. if fluoride levels 
were associated with all type of bone cancer then the study design would not be able to detect 
any difference in risk. 
Our findings are in agreement with findings from a recent large case-control study by Archer 
et. al.83 Adjusted unconditional logistic regression analyses stratified by sex and age category 
(6-8, 9-12, 13-15 and 16+) yielded no evidence of association. However, incomplete 
residence information and the control selection procedure (controls being other cancer 
patients), could have introduced bias. 
To explore the robustness of our findings, a series of sensitivity analyses were performed. 
Individuals with other cancer diagnosis prior to index date (osteosarcoma diagnosis) were 
excluded, and individuals with missing fluoride exposure values were assigned values 
(impute) based on their existing fluoride values (lowest and highest). The results did not alter 
in any of the sensitivity analyses.  
However, this study has a few important limitations. We lack information on potential 
confounders such as additional socioeconomic variables and height at diagnosis. Moreover, 
misclassification of exposure when we only assess fluoride exposure from drinking water, 
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other dietary source for fluoride (food, beverages, and dental hygiene products) might 
account for an important part of the total fluoride load in younger age groups.27,34 And 
additionally, non-differential misclassification of exposure (i.e. individuals categorized as 
exposed could in fact be unexposed and vice versa). We cannot rule out that the above 
mentioned methodological limitations may have influenced the results. 
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7 CONCLUSIONS 
 
The results of this thesis add to the body of evidence that ingestion of lower fluoride 
concentrations (<4 mg/L) is not associated with increased risk of adverse health effects. The 
major strengths of this thesis is the population-based study design applied in all three studies, 
the relatively large number of study subjects, which increased the precision, and additionally, 
that all data were collected prospectively. 
 
Specific conclusions of the three studies: 
 
I. Long term exposure to drinking water fluoride up to 2.7 mg/L seems unlikely to 
have any important effects on hip fracture risk in Sweden. Additionally, we did 
not find an association between fluoride level and the risk of osteoporotic (low-
trauma) hip fracture. Stratified analyses suggested that fluoride exposure in 
individuals younger than 80 years of age was associated with a decreased risk for 
hip fracture. However, no clear exposure-response effect was observed 
 
II. Long term exposure to drinking water fluoride up to 2.7 mg/L seems unlikely to 
have any important effects on myocardial infarction risk in Sweden. Additional 
analyses was performed, looking at fatal and non-fatal myocardial infarction. No 
association was found. We found some evidence of a positive association between 
fluoride exposure level and risk of myocardial infarction in the northern part of 
Sweden. This association may in part be explained by unmeasured confounding. 
Moreover, only a small effect size is detected, and in combination with the large 
sample size and total number of events, we consider that this finding is unlikely to 
be of significance. 
 
III. Given the limitations, no association was found between drinking water fluoride 
levels up to 2.7 mg/L and osteosarcoma risk in Sweden. No age-, time-, or sex-
specific associations were detected. 
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8 FUTURE PERSPECTIVES 
 
Throughout this thesis, only the fluoride content of the drinking water was assessed and 
evaluated. Even though, drinking water is the biggest contributor to fluoride exposure, future 
research projects investigating the association between health effects and ingested fluoride, 
should also include fluoride from other sources, such as food, beverages, and ingested 
fluoride from dental hygiene products. 
 
Ingested fluoride is mainly eliminated and excreted via the kidneys. Future studies on the 
association between ingested fluoride and health risk in individuals with renal impairments, 
in whom more fluoride may be retained than in healthy individuals. 
 
Future studies on the effect of ingested fluoride on human intelligence. Human studies of 
ingested fluoride have been reporting adverse behavioral and cognitive effects. However, the 
studies suffer from methodological limitations, and the exposure levels are high and not 
applicable to Swedish populations. 
 
Future studies on the association between ingested fluoride and health risks in a bottled-fed 
population, which might have ingested a higher amount of fluoride than a breast-fed 
population. 
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